TIME COURSE OF IL1 AND IL6 SYNTHESIS AND RELEASE IN HUMAN BRONCHIAL EPITHELIAL-CELL CULTURES EXPOSED TO TOLUENE DIISOCYANATE

被引:39
作者
MATTOLI, S [1 ]
COLOTTA, F [1 ]
FINCATO, G [1 ]
MEZZETTI, M [1 ]
MANTOVANI, A [1 ]
PATALANO, F [1 ]
FASOLI, A [1 ]
机构
[1] UNIV MILAN,IST RIC FARMACOL MARIO NEGRI,CATTEDRA CHIRURG TORAC,I-20122 MILAN,ITALY
关键词
D O I
10.1002/jcp.1041490212
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously demonstrated that human bronchial epithelial cells release appreciable amounts of interleukin 1 (IL1) and interleukin 6 (IL6) when exposed to toluene diisocyanate (TDI) in vitro. TDI is an inflammatory and asthmogenic stimulus presumed to act at least in part through immunological mechanisms. The epithelial cell-derived IL1 and IL6 can promote T cell activation and proliferation in culture, and if this also happens in vivo they may contribute to the persistence of the inflammatory response of the bronchial mucosa observed in TDI-sensitive asthmatics. In this study, we confirmed the release of biologically active IL1-beta and IL6-like substances from bronchial epithelial cells exposed to isocyanates in vitro, and related the rate and the magnitude of the cytokine secretion with the pattern of IL1-beta and IL6 gene expression and the extent of epithelial cell injury. in the epithelial cell cultures exposed to TDI, there was a parallel, progressive increase in the expression of IL6 mRNA and in the secretion of IL6 protein between 48 hours and 6 days after exposure. By contrast, although increasing amounts of biologically active IL1-beta were detected in the supernatants of TDI-exposed epithelial cells throughout the 6-day period following exposure, augmented levels of IL1-beta mRNA were only evident 6 days after exposure, suggesting that TDI exposure might have initially affected the enzymatic cleavage of the intracellular IL1-beta precursor and the mechanisms which regulate the secretion of mature IL1-beta.
引用
收藏
页码:260 / 268
页数:9
相关论文
共 36 条
  • [1] ALLEGRA L, 1988, EUR RESPIR J, V2, pS450
  • [2] NUCLEOTIDE-SEQUENCE OF HUMAN MONOCYTE INTERLEUKIN-1 PRECURSOR CDNA
    AURON, PE
    WEBB, AC
    ROSENWASSER, LJ
    MUCCI, SF
    RICH, A
    WOLFF, SM
    DINARELLO, CA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (24): : 7907 - 7911
  • [3] AVERY SB, 1969, CLIN EXP IMMUNOL, V4, P585
  • [4] NEW CONCEPTS IN THE PATHOGENESIS OF BRONCHIAL HYPERRESPONSIVENESS AND ASTHMA
    BARNES, PJ
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (06) : 1013 - 1026
  • [5] ISOCYANATE-INDUCED PULMONARY-DISEASES - A CURRENT PERSPECTIVE
    BERNSTEIN, IL
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1982, 70 (01) : 24 - 31
  • [6] INTERLEUKIN-1 ACTS ON CULTURED HUMAN VASCULAR ENDOTHELIUM TO INCREASE THE ADHESION OF POLYMORPHONUCLEAR LEUKOCYTES, MONOCYTES, AND RELATED LEUKOCYTE CELL-LINES
    BEVILACQUA, MP
    POBER, JS
    WHEELER, ME
    COTRAN, RS
    GIMBRONE, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) : 2003 - 2011
  • [7] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [8] EXPRESSION OF C-FOS PROTOONCOGENE IN NORMAL HUMAN PERIPHERAL-BLOOD GRANULOCYTES
    COLOTTA, F
    WANG, JM
    POLENTARUTTI, N
    MANTOVANI, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (04) : 1224 - 1229
  • [9] CUSS FM, 1987, AM REV RESPIR DIS, V36, P32
  • [10] DECRAIR M, 1983, INT ARCH OCC ENV HEA, V52, P257